RTS-28 Reporting Obligations 2021

Mackenzie Investments Europe Limited*
RTS-28/Art 65(6) Disclosure for the period from January 1 to December 31 2021

Published Under Article 65(6) of the Commission Delegated Regulation (EU) 2017/565 (Markets in Financial Instruments Directive II)

RTS-28 REPORTING OBLIGATIONS

As part of an investment firm's best execution processes, The Markets in Financial Instruments Directive (MiFID II) requires asset managers to report their top five brokers for all trading.

The 2021 calendar year report for Equities – Shares and Depositary Receipts (Tick Band 1 and 2) can be found by clicking here.

The 2021 calendar year report for Equities – Shares and Depositary Receipts (Tick Band 3 and 4) can be found by clicking here.

The 2021 calendar year report for Equities – Shares and Depositary Receipts (Tick Band 5 and 6) can be found by clicking here

The 2021 calendar year report for Exchange Traded Products can be found by clicking here.

The 2021 calendar year report for Other Instruments can be found by clicking here.

The full 2021 calendar year report containing all information can be found by clicking here

Professional Clients

Class of Instrument

Equity Liquidity Bands 1-2

<1 Average trade per business day

N

Counterparty

Volume Traded (%)

Proportion of Orders Executed

Directed Trade (% Volume

Instinet

21.3%

15.8%

0.0%

Barclays

13.1%

10.7%

0.0%

DAVY

8.7%

4.0%

0.0%

Virtu

8.6%

26.5%

0.0%

Numis

8.2%

7.2%

0.0%

Class of Instrument

Equity Liquidity Bands 3-4

<1 Average trade per business day

N

Counterparty

Volume Traded (%)

Proportion of Orders Executed

Directed Trade (% Volume

Citigroup

21.8%

9.0%

0.0%

Virtu

16.2%

42.0%

0.0%

Kepler

9.6%

7.1%

0.0%

Exane

8.3%

9.2%

0.0%

Baader

7.1%

3.1%

0.0%

Class of Instrument

Equity Liquidity Bands 5-6

<1 Average trade per business day

N

Counterparty

Volume Traded (%)

Proportion of Orders Executed

Directed Trade (% Volume

Virtu

21.4%

35.6%

0.0%

Kepler

18.1%

14.5%

0.0%

Exane

12.5%

11.3%

0.0%

Instinet

7.9%

8.3%

0.0%

Barclays

7.1%

6.4%

0.0%

Class of Instrument

Exchange Traded Products

<1 Average trade per business day

Y

Counterparty

Volume Traded (%)

Proportion of Orders Executed

Directed Trade (% Volume

GFIS

100.0%

100.0%

0.0%

 

Class of Instrument

Other

<1 Average trade per business day

Y

Counterparty

Volume Traded (%)

Proportion of Orders Executed

Directed Trade (% Volume

Barclays

25.3%

25.0%

0.0%

Goldman

21.3%

4.2%

0.0%

Instinet

17.0%

29.2%

0.0%

Goodbody

6.2%

4.2%

0.0%

Virtu

4.8%

12.5%

0.0%

Qualitative Data for RTS 28 for period from January 1 to December 31 2021

Equities - Analysis and conclusions from monitoring the quality of execution in accordance with Commission Delegated Regulation (EU) 2017/576 Article 3(3)(a) to (f)

a) Our execution process is designed ensure the best possible execution on a consistent basis considering the following factors;

  • Price
  • Cost
  • Likelihood of execution
  • Speed
  • Confidentiality from our counterparty
  • Liquidity
  • Settlement

b) Mackenzie Investments Europe Limited has no close links, conflicts of interest or ownership with any brokers used to execute orders

c) The firm doesn't have any arrangements with any execution venues regarding payments made or received, discounts, rebates or non‐ monetary benefits received

d) We continually assess execution venues to ensure they provide us the highest quality execution on a consistent basis

e) All our clients are professional

f) Not applicable as we do not execute retail client orders

g) All trades are monitored and reviewed to ensure the highest quality of execution

h) Not applicable as we have not used the output of a consolidated tape provider